DAIC

MAY 16, 2024

Apparent treatment-resistant hypertension is defined as the need to take three or more types of anti-high blood pressure medication daily and is associated with an increased risk for stroke , coronary heart disease , heart failure , and all-cause mortality. Over a period of 9.5 of white adults.

Hypertension 105

Hypertension Blood Pressure Health Disparities Heart Attack 105

Dr. Sanjay Gupta

MARCH 6, 2022

Today’s video is on the subject of heart failure. Heart failure is a chronic clinical syndrome characterised by the inability of the heart to pump out enough blood to meet the body’s requirements. Anything that affects the heart in a bad way may in its severest form lead to heart failure.

Heart Failure 40

Heart Failure Quality of Life ACE Inhibitor Exercise 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

from 2016‐2019 and secondary diagnosis of T2DM. Data was weighted to allow for representative nationwide estimates.ResultsWe identified 426,549 patients who were admitted with a primary diagnosis of TIA between 2016 and 2019. The primary diagnosis of the readmission was used to identify the etiology of readmission.

Diabetes 40

Diabetes Coronary Artery Disease Atrial Fibrillation Dementia 40

Dr. Paddy Barrett

AUGUST 15, 2023

Insulin resistance is a core risk factor for the three leading causes of death: Cardiovascular Disease Cancer Dementia. With no insulin resistance and high APOB (LDL-C), the risk of future heart events increases by about 80%. Subscribe now Take cardiovascular disease, for example. PMID: 19138424; PMCID: PMC2635363. doi: 10.1089/met.2018.0105.

Blood Pressure 52

Blood Pressure Risk Factors Diabetes Cholesterol 52

Dr. Smith's ECG Blog

APRIL 8, 2015

History of Cardiovascular disease (all studies): Especially any history of heart failure or structural cardiac disease, including valvular 4. Finally, much of this correlates well with The new Canadian Syncope Arrhythmia Risk Score , just published in 2016, results of which are given below in the Annotated Bibliography.

Arrhythmia 52

Arrhythmia Outcomes Chest Pain Risk Factors 52

Dr. Malcolm Kendrick

OCTOBER 30, 2024

(2022-25) Swiss Reinsurance Company: £645K China Kadoorie Biobank (2002-ongoing) AstraZeneca: $300K Bayer AG: £300K GlaxoSmithKline: £3.6M Elinogrel feasibility trial (2010-2011) Novartis: £500K EMPA-KIDNEY (2017-ongoing) Boehringer Ingelheim: £106.3M Establishing Fuwai-Oxford research centre (2010-ongoing) Merck: £1.1M

Cholesterol 145

Cholesterol Article Research Diet 145